Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...

Vertex Pharmaceuticals P/E Compared to Competitors. The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, histo ...

Third, this stock provides stability to investors' portfolios in the event the economy takes a turn for the worse in the new ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks ...

Vertex Pharmaceuticals (NDAQ: VRTX) stands today as a top 20 pharma company with over a $100 billion market cap. But this biotech beacon has ridden a bumpy path to its current perch and, along the way ...

Elsewhere, the company's Casgevy, approved some two years ago to treat two rare blood disorders, could also make commercial ...

Vertex Pharmaceuticals Incorporated VRTX stock has declined 8.9% in the past three months. The deterioration was due to soft first-quarter results, slower-than-expected uptake of its newer drugs as ...

Vertex Inc. (NASDAQ:VERX) is one of the best beaten down stocks to invest in according to analysts. On December 5, Vertex Inc ...

Vertex Pharmaceuticals has inched closer to bringing a new, non-opioid med to the blockbuster pain market, with the FDA accepting a rolling new drug application for the company’s NaV1.8 inhibitor ...

An update from Vertex Minerals Ltd. ( ($AU:VTX) ) is now available. Vertex Minerals director Tully Richards has increased his holding in the ...